With the lame-duck session underway, U.S. Rep. Chris Pappas, (D-N.H., 1st District) is pressing ahead with a bill that would provide additional support for veterans' mental health needs.
The congressman is optimistic that President Donald Trump will sign the bipartisan bill, given his past support for legislation supporting veterans.
"He signed other legislation and issued executive orders on this topic as well, so I think his interest is there," Pappas told Cheddar. "It really should be about doing what's best for the end veteran and not based on politics."
The Veterans COMPACT Act of 2020 aims to improve the transition phase from active duty to veteran status with a more robust network of support services. This would include extending outreach to veterans about existing services, raising awareness among family members, setting up a pilot program to identify service gaps, and eliminating costs for emergency mental health care.
The bill passed unanimously in both the House and Senate.
"This is an issue that is top-of-mind to so many of our policymakers and so many of our veteran service organizations," Pappas said. "We've got to find a way to lower the number of veterans that take their lives by suicide each and every day in this country."
A total of 6,435 U.S. veterans committed sucided in 2018, according to the latest data from the Department of Veteran Affairs, a rate 50 percent higher than for non-veteran adults.
High levels of suicide among veterans have persisted since 2005, even as the demographics of the population have shifted over time.
"The fastest growing group of veterans is women veterans, and they're not necessarily welcomed into VA," he said. "It's a service that was created for a different generation, so we've got to bring into the 21st century."
He'd also like to see a fresh face at the head of the agency. In particular, Pappas said that former Democratic presidential candidate Pete Buttigieg would be a "transformational choice," but that he looks forward to "working with whoever is chosen by President Biden."
Jill and Carlo cover the latest on Omicron, another school shooting in America and more. Plus, bidding farewell to 'transitory' inflation, and the controversy surrounding 'Lovely Bones' author Alice Sebold.
Disparities in tree coverage across America is a huge issue that affects air quality, heat exposure, and ultimately determines how resilient communities are against climate change. The Build Back Better Act is allocating $2.5 billion to boost 'tree equity.' Lemir Teron, assistant professor at SUNY College of Environmental Science and Forestry, joins Cheddar News to explain why this is a priority for Democrats today.
The Supreme Court will be hearing arguments in Dobbs v. Jackson Women's Health on Wednesday over a Mississippi law banning abortions after 15 weeks. Jimmy Hoover, the Supreme Court editor-at-large for Law360, joined Cheddar to break down the momentous legal fight. "This is the biggest abortion case at the Supreme Court in 30 years," he said. "It is a … a direct challenge to Roe v. Wade."
Matt Peron, Director of Research at Janus Henderson Investors, joins Cheddar News' Closing Bell, where he breaks down the factors leading to today's market slide and says there's more to it than Fed Chair Jerome Powell's comments about speeding up tapering efforts.
Walmart CEO Dough McMillon praised the Biden administration's efforts to ease supply chain constraints after the company saw a 26 percent jump in shipments over the last month. President Joe Biden had announced back in October that California ports would operate on a 24/7 basis.
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
